What’s more valuable: a patent or a Nobel Prize?

In 2020 Jennifer Doudna from the University of California at Berkeley was awarded the Nobel Prize in chemistry alongside colleague Emmanuelle Charpentier from the University of Vienna for their work developing CRISPR-Cas9, a genome editing breakthrough that has revolutionized biomedicine. Aside from the scientific bragging rights, the Nobel win grants Doudna access to special free parking on the Berkeley campus.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]